Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 419

1.

Epithelial-stromal tumor of the seminal vesicles in the transgenic adenocarcinoma mouse prostate model.

Tani Y, Suttie A, Flake GP, Nyska A, Maronpot RR.

Vet Pathol. 2005 May;42(3):306-14.

PMID:
15872376
[PubMed - indexed for MEDLINE]
Free Article
2.

Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

Yeh IT, Reddick RL, Kumar AP.

Prostate. 2009 May 15;69(7):755-60. doi: 10.1002/pros.20924.

PMID:
19170049
[PubMed - indexed for MEDLINE]
3.

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ.

Lab Invest. 1998 Mar;78(3):319-33. Corrected and republished in: Lab Invest. 1998 Jun;78(6):i-xv.

PMID:
9520945
[PubMed - indexed for MEDLINE]
4.

Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.

Kasper S, Sheppard PC, Yan Y, Pettigrew N, Borowsky AD, Prins GS, Dodd JG, Duckworth ML, Matusik RJ.

Lab Invest. 1998 Jun;78(6):i-xv.

PMID:
9645768
[PubMed - indexed for MEDLINE]
5.

A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.

Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ.

Cancer Res. 2001 Mar 1;61(5):2239-49.

PMID:
11280793
[PubMed - indexed for MEDLINE]
Free Article
6.

Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.

Wikström P, Lindahl C, Bergh A.

Prostate. 2005 Feb 1;62(2):148-64.

PMID:
15389804
[PubMed - indexed for MEDLINE]
7.

Phyllodes tumor of the seminal vesicle: case report and literature review.

Son HJ, Jeong YJ, Kim JH, Chung MJ.

Pathol Int. 2004 Dec;54(12):924-9.

PMID:
15598315
[PubMed - indexed for MEDLINE]
9.

Altered expression of transforming growth factor betas during urethral and bulbourethral gland tumor progression in transgenic mice carrying the androgen-responsive C3(1) 5' flanking region fused to SV40 large T antigen.

Shibata MA, Jorcyk CL, Devor DE, Yoshidome K, Rulong S, Resau J, Roche N, Roberts AB, Ward JM, Green JE.

Carcinogenesis. 1998 Jan;19(1):195-205.

PMID:
9472712
[PubMed - indexed for MEDLINE]
Free Article
11.

Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice.

Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, Kisiel N, Vujcic S, Mazurchuk RV, Porter CW.

J Biol Chem. 2004 Sep 17;279(38):40076-83. Epub 2004 Jul 13.

PMID:
15252047
[PubMed - indexed for MEDLINE]
Free Article
12.

Cystosarcoma phyllodes of the seminal vesicle.

Fain JS, Cosnow I, King BF, Zincke H, Bostwick DG.

Cancer. 1993 Mar 15;71(6):2055-61.

PMID:
8382998
[PubMed - indexed for MEDLINE]
13.

MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma.

Leroy X, Ballereau C, Villers A, Saint F, Aubert S, Gosselin B, Porchet N, Copin MC.

Am J Surg Pathol. 2003 Apr;27(4):519-21.

PMID:
12657938
[PubMed - indexed for MEDLINE]
14.

Use of tissue recombination to predict phenotypes of transgenic mouse models of prostate carcinoma.

Ishii K, Shappell SB, Matusik RJ, Hayward SW.

Lab Invest. 2005 Sep;85(9):1086-103.

PMID:
15980886
[PubMed - indexed for MEDLINE]
Free Article
16.

Spontaneous mutation in mice provides new insight into the genetic mechanisms that pattern the seminal vesicles and prostate gland.

Marker PC, Dahiya R, Cunha GR.

Dev Dyn. 2003 Apr;226(4):643-53.

PMID:
12666202
[PubMed - indexed for MEDLINE]
Free Article
17.

Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, Cardiff RD, Cunha GR, Balmain A.

Am J Pathol. 2008 Jan;172(1):236-46. Epub 2007 Dec 21.

PMID:
18156212
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.

Neeley YC, Arredouani MS, Hollenbeck B, Eng MH, Rubin MA, Sanda MG.

Prostate. 2008 May 15;68(7):715-27. doi: 10.1002/pros.20689.

PMID:
18302222
[PubMed - indexed for MEDLINE]
19.

Cystic epithelial-stromal tumor of the seminal vesicle.

Mazur MT, Myers JL, Maddox WA.

Am J Surg Pathol. 1987 Mar;11(3):210-7.

PMID:
3030148
[PubMed - indexed for MEDLINE]
20.

Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.

Raghow S, Hooshdaran MZ, Katiyar S, Steiner MS.

Cancer Res. 2002 Mar 1;62(5):1370-6.

PMID:
11888907
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk